Yvonne Ou, MD

Ophthalmologist

Dr. Yvonne Ou is a board certified ophthalmologist who specializes in glaucoma, including medical, laser and surgical therapies; cataract evaluation and treatment including combined cataract and glaucoma surgery; and glaucoma implant surgery. Her research interests include glaucoma, in particular, applying neural stem cell biology to the characterization and therapy of glaucoma. Other research interests include the relationship between glaucoma and other neurodegenerative diseases.

Ou earned her medical degree from Harvard Medical School and completed her residency in ophthalmology at Jules Stein Institute, UCLA. She has fellowship training from Duke University Eye Center in clinical glaucoma and research glaucoma.

Ou is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the American Glaucoma Society, Women in Ophthalmology and Prevent Blindness Northern California.

Clinics

Glaucoma Clinic
8 Koret Way, Suite U519
San Francisco, CA 94143-0644
Phone: (415) 514–6920
Fax: (415) 514–6925

Hours: Monday to Friday, 8 a.m. to 5 p.m.

Board Certification

Ophthalmology, American Board of Ophthalmology

Academic Title

Associate Professor

More about Yvonne Ou

Additional Languages

Mandarin

Education

Harvard School of Medicine, Biochemical Sciences 2004

Residencies

Jules Stein Eye Institute, UCLA, Ophthalmology 2008

Fellowships

Duke University Medical Center, Clinical Glaucoma 2009
Duke University Medical Center, Research Glaucoma 2010

Selected Research and Publications

  1. Santina LD, Ou Y. Biolistic Labeling of Retinal Ganglion Cells. Methods Mol Biol. 2018; 1695:161-170.
  2. Zhang L, Li G, Shi M, Liu HH, Ge S, Ou Y, Flanagan JG, Chen L. Establishment and Characterization of an Acute Model of Ocular Hypertension by Laser-Induced Occlusion of Episcleral Veins. Invest Ophthalmol Vis Sci. 2017 08 01; 58(10):3879-3886.
  3. Mao M, Kiss M, Ou Y, Gould DB. Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse. Dis Model Mech. 2017 04 01; 10(4):475-485.
  4. Ou Y, Jo RE, Ullian EM, Wong RO, Della Santina L. Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension. J Neurosci. 2016 08 31; 36(35):9240-52.
  5. Della Santina L, Ou Y. Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma. Exp Eye Res. 2017 05; 158:43-50.
  6. Kuo DS, Ou Y, Jeng BH, Bhisitkul R, Stewart JM, Duncan JL, Han Y. Correlation of Serial Scleral and Corneal Pneumatonometry. Ophthalmology. 2015 Sep; 122(9):1771-6.
  7. Schallhorn JM, Schallhorn SC, Ou Y. Factors that influence intraocular pressure changes after myopic and hyperopic LASIK and photorefractive keratectomy: a large population study. Ophthalmology. 2015 Mar; 122(3):471-9.
  8. Lin CC, Chen A, Jeng BH, Porco TC, Ou Y, Han Y. Scleral intraocular pressure measurement in cadaver eyes pre- and postkeratoprosthesis implantation. Invest Ophthalmol Vis Sci. 2014 Apr 09; 55(4):2244-50.
  9. Law SK, Tamboli DA, Ou Y, Giaconi JA, Caprioli J. Development of a resident training module for systematic optic disc evaluation in glaucoma. J Glaucoma. 2012 Dec; 21(9):601-7.
  10. Ou Y, Grossman DS, Lee PP, Sloan FA. Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis. Ophthalmic Epidemiol. 2012 Oct; 19(5):285-92.
  11. Ou Y, Caprioli J. Surgical management of pediatric glaucoma. Dev Ophthalmol. 2012; 50:157-72.
  12. Ou Y, Goldberg I, Migdal C, Lee PP. A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology. 2011 Jun; 118(6):1017-23.
  13. Ou Y, Yu F, Law SK, Coleman AL, Caprioli J. Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma. Arch Ophthalmol. 2009 Nov; 127(11):1436-41.
  14. Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, Huang TN, Jung WG, Kuo TY, Sheng M, Wang TF, Hsueh YP. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron. 2004 Apr 08; 42(1):113-28.
  15. Wang TF, Ou Y, Guidotti G. The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure. J Biol Chem. 1998 Sep 18; 273(38):24814-21.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.